<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BICD2</id>
	<title>BICD2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BICD2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BICD2&amp;action=history"/>
	<updated>2026-06-11T08:53:06Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=BICD2&amp;diff=5179&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Protein bicaudal D homolog 2 (Bic-D 2) [KIAA0699]  ==Publications==  {{medline-entry |title=A novel mouse model with impaired dynein/dynactin function develops am...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BICD2&amp;diff=5179&amp;oldid=prev"/>
		<updated>2021-05-12T13:32:52Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Protein bicaudal D homolog 2 (Bic-D 2) [KIAA0699]  ==Publications==  {{medline-entry |title=A novel mouse model with impaired dynein/dynactin function develops am...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Protein bicaudal D homolog 2 (Bic-D 2) [KIAA0699]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in [[SOD1]]-ALS mice.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/18579581&lt;br /&gt;
|abstract=Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition characterized by progressive motor neuron degeneration and muscle paralysis. Genetic evidence from man and mouse has indicated that mutations in the dynein/dynactin motor complex are correlated with motor neuron degeneration. In this study, we have generated transgenic mice with neuron-specific expression of Bicaudal D2 N-terminus ([[BICD2]]-N) to chronically impair dynein/dynactin function. Motor neurons expressing [[BICD2]]-N showed accumulation of dynein and dynactin in the cell body, Golgi fragmentation and several signs of impaired retrograde trafficking: the appearance of giant neurofilament swellings in the proximal axon, reduced retrograde labelling by tracer injected in the muscle and delayed expression of the injury transcription factor [[ATF3]] after axon transection. Despite these abnormalities, [[BICD2]]-N mice did not develop signs of motor neuron degeneration and motor abnormalities. Interestingly, the [[BICD2]]-N transgene increased lifespan in &amp;#039;low copy&amp;#039; [[SOD1]]-G93A ALS transgenic mice. Our findings indicate that impaired dynein/dynactin function can explain several pathological features observed in ALS patients, but may be beneficial in some forms of ALS.&lt;br /&gt;
|mesh-terms=* Amyotrophic Lateral Sclerosis&lt;br /&gt;
* Animals&lt;br /&gt;
* Biological Transport&lt;br /&gt;
* Carrier Proteins&lt;br /&gt;
* Cells, Cultured&lt;br /&gt;
* Disease Models, Animal&lt;br /&gt;
* Dynactin Complex&lt;br /&gt;
* Dyneins&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Expression&lt;br /&gt;
* Golgi Apparatus&lt;br /&gt;
* Humans&lt;br /&gt;
* Life Expectancy&lt;br /&gt;
* Male&lt;br /&gt;
* Membrane Proteins&lt;br /&gt;
* Mice&lt;br /&gt;
* Mice, Transgenic&lt;br /&gt;
* Microtubule-Associated Proteins&lt;br /&gt;
* Motor Neurons&lt;br /&gt;
* Rats&lt;br /&gt;
* Superoxide Dismutase&lt;br /&gt;
* Superoxide Dismutase-1&lt;br /&gt;
* Survival&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1093/hmg/ddn182&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>